Fexofast-180 Adverse Reactions

In controlled clinical trials, the most commonly reported adverse effects were headache, drowsiness, nausea, dizziness and fatigue. The incidence of these events observed with Fexofenadine was similar to that observed with placebo.
The following side/adverse effects have been selected on the basis of their potential clinical significance (possible signs and symptoms in parentheses where appropriate) - not necessarily inclusive: Those indicating need for medical attention: Incidence rare - Observed during clinical practice: Anaphylaxis and hypersensitivity reactions (chest tightness; feeling of warmth redness of the face, neck, arms and occasionally, upper chest; large, hive-like swelling on face, eyelids, lips, tongue, throat, hands, legs, feet, sex organs; shortness of breath, difficult or labored breathing).
Those indicating need for medical attention only if they continue or are bothersome: Incidence less frequent: Back pain; dizziness, drowsiness; dysmenorrhea (painful menstrual bleeding); dyspepsia (stomach upset); fatigue (unusual feeling of tiredness); headache; nausea; sinusitis (headache; pain or tenderness around eyes or cheekbones; runny or stuffy nose); viral infections such as cold, flu.
Incidence rare - Observed during clinical practice: Nervousness; rash - urticarial and pruritic; sleep disorders (sleeplessness; terrifying dreams; trouble sleeping).